From left, Seo Jung-jin, co-founder of Celltrion, and Kim Kang-lip, head of the Ministry of Food and Drug Safety, look at a sample of CT-P59, a coronavirus treatment candidate, at a Celltrion factory in Incheon on Monday. On Feb. 5, the ministry granted conditional approval for Celltrion to market its Covid-19 treatment.
YONHAP